ARTICLE

FindCenter AddIcon

FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression

By Yasemin Saplakoglu — 2019

The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).

Read on www.livescience.com

FindCenter Post-Image

The Future of Psychedelic Medicine

This is an exciting time to be involved in psychedelic research. Medical researchers are rediscovering the possible benefits of responsible use of psychedelics in therapeutic settings.

FindCenter AddIcon

EXPLORE TOPIC

Psilocybin